Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Benchmarks of meaningful impairment on the MSFC and BICAMS.
Neuromyelitis optica and pregnancy.
MicroRNA Expression Changes during Interferon-Beta Treatment in the Peripheral Blood of Multiple Sclerosis Patients.
Multiple sclerosis: RBPJ identified as an autoantigen in multiple sclerosis.
The diadenosine homodinucleotide P18 improves in vitro myelination in experimental Charcot-Marie-Tooth type 1A.
Bipolar disorder and multiple sclerosis: A case series.
Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis.
The role of the parent compound vitamin d with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes.
Reducing survey burden: feasibility and validity of PROMIS measures in multiple sclerosis.
A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
[Kidney function tests in multiple sclerosis].
Cell-Based Modulation of Autoimmune Responses in Multiple Sclerosis and Experimental Autoimmmune Encephalomyelitis: Therapeutic Implications.
Imipramine and fluoxetine inhibit LPS-induced activation and affect morphology of microglial cells in the rat glial culture.
[Vitamin D and multiple sclerosis].
Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment.
Association of smoking with risk of multiple sclerosis: a population-based study.
MicroRNA-21 with therapeutic potential in autoimmune diseases.
Correction: Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine.
LIVER X RECEPTORS, NERVOUS SYSTEM AND LIPID METABOLISM.
STAT3 Activates miR-155 in Th17 cells and Acts in Concert to Promote Experimental Autoimmune Uveitis.
Nitric oxide inhibits CXCL12 expression in neuroinflammation.
Multiple Sclerosis from Bench to Bedside.
Prolactin in multiple sclerosis.
Induction of intestinal Th17 cells by segmented filamentous bacteria.
New data presented at 29th ECTRIMS congress reinforce the clinical profile of investigational laquinimod on disease progression and inflammation in relapsing-remitting multiple sclerosis

Pages